期刊
CHEMICAL RESEARCH IN TOXICOLOGY
卷 17, 期 8, 页码 999-1006出版社
AMER CHEMICAL SOC
DOI: 10.1021/tx049904e
关键词
-
Clinical chelation therapy of mercury poisoning generally uses one or both of two drugs-meso-dimercaptosuccinic acid (DMSA) and dimercaptopropanesulfonic acid (DMPS), commercially sold as Chemet and Dimaval, respectively. We have used a combination of mercury L-III-edge X-ray absorption spectroscopy and density functional theory calculations to investigate the chemistry of interaction of mercuric ions with each of these chelation therapy drugs. We show that neither DMSA nor DMPS forms a true chelate complex with mercuric ions and that these drugs should be considered suboptimal for their clinical task of binding mercuric ions. We discuss the design criteria for a mercuric specific chelator molecule or custom chelator, which might form the basis for an improved clinical treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据